IBI115
/ Innovent Biologics
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 05, 2026
Safety and Preliminary Activity of BI115 in Advanced SCLC
(clinicaltrials.gov)
- P1 | N=150 | Recruiting | Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Monotherapy • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor
May 01, 2026
Safety and Preliminary Activity of BI115 in Advanced SCLC
(clinicaltrials.gov)
- P1 | N=150 | Not yet recruiting | Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Monotherapy • New P1 trial • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor
1 to 2
Of
2
Go to page
1